Gabapentin Tablet
Product Images NDC 63187-010

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63187-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Gabapentin (522c5010 38dd 4f7f B251 0c8dd50e1f35 01)

Chemical structure of the active ingredient gabapentin, showing its characteristic cyclohexane ring with attached amino and carboxyl functional groups.*

FDA Label Image

Figure 1 (522c5010 38dd 4f7f B251 0c8dd50e1f35 02)

A line graph showing mean pain scores over 8 weeks for placebo and gabapentin (3600 mg/day) groups. The x-axis represents weeks including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin group scores decrease significantly compared to placebo across the timeline.*

FDA Label Image

Figure 2 (522c5010 38dd 4f7f B251 0c8dd50e1f35 03)

A line graph showing mean pain scores over a 7-week period comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, and the y-axis represents mean pain score from 0 to 10. Gabapentin treatment groups show a notable decrease in pain scores compared to placebo during both the 3-week dose titration and 4-week fixed dose periods.*

FDA Label Image

Figure 3 (522c5010 38dd 4f7f B251 0c8dd50e1f35 04)

A bar chart comparing the percentage of responders at endpoint for Gabapentin (GBP) doses and placebo (PBO) in two separate studies. Study 1 shows a 12% response rate for placebo and 29% for GBP 3600 mg. Study 2 shows a 14% response rate for placebo and increased responses for GBP 1800 mg (32%) and GBP 2400 mg (34%). Statistical significance indicated for GBP groups versus placebo.*

FDA Label Image

Figure 4 (522c5010 38dd 4f7f B251 0c8dd50e1f35 05)

A scatter plot comparing differences (%) across three studies labeled 'a', 'b', and 'c' at various daily doses of Gabapentin in milligrams (600, 900, 1200, 1800 mg). The graph shows increasing difference percentages with higher doses for each study, represented by distinct symbols and shading.*

FDA Label Image

Glenmark Logo (522c5010 38dd 4f7f B251 0c8dd50e1f35 06)

FDA Label Image

Glenmark Logo (522c5010 38dd 4f7f B251 0c8dd50e1f35 07)

FDA Label Image

63187-010-30 (522c5010 38dd 4f7f B251 0c8dd50e1f35 08)

Gabapentin 800 mg tablet label from Proficient Rx LP showing a 30-count package. The label states each tablet contains 800 mg of gabapentin USP, describing the tablets as white to off-white, film-coated, oval-shaped, and biconvex, debossed with "G" and "13" on one side. Manufacturer is Glenmark Pharmaceuticals Ltd., India. Storage temperature and safety warnings are included.*

FDA Label Image

Gabapentin 600mg (Gabapentin 600mg)

Label for Gabapentin 600 mg tablets, quantity of 90, labeled for prescription use only. The product is film-coated, oval-shaped tablets with biconvex scoring, debossed with 'G' and '31' on one side. Manufactured by Glenmark Pharmaceuticals Ltd. India and packaged by Proficient Rx LP in Thousand Oaks, CA. Storage instructions and medication warnings appear on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.